New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
December 28, 2012
07:07 EDTOMEROmeros price target lowered to $16 from $19 at Burrill
Burrill lowered its price target for Omeros after the company announced that OMS103HP did not meet its primary endpoint in patients undergoing arthroscopic partial meniscectomy surgery. The firm notes that OMS103HP achieved statistically significant reduction of postoperative pain, though, and keeps an Outperform rating on the stock.
News For OMER From The Last 14 Days
Check below for free stories on OMER the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
There are no results for OMER

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use